Providing comprehensive services to the med tech industry
Entwicklung von medizinischen Geräten und Diagnostik
Access global regulatory expertise across every stage of med tech product development.
Partner with an experienced, dedicated medical device and diagnostic development team.
ISO 13485 certification: reducing your oversight and audit requirements.
The requirements needed to develop medical devices and diagnostic products-and successfully bring them to market-continue to evolve. This necessitates a deep knowledge of the evolving regulatory environments globally and a keen understanding of efficient and effective trial design to achieve your goals. Drawing from our experience advancing more than 740 device and diagnostic trials run in the last five years, our team at Fortrea is ready to help.
Advance life-changing medical devices from concept to approval.
Our team of medical device, imaging and drug-device combination specialists can provide consulting to support your:
- Global regulatory submissions, including Clinical Evaluation Reports (CERs)
- Protokollentwicklung
- Global clinical trial design and execution
- Post-market studies
- Design control support
Accelerate IVD development with global clinical validation services.
Our experienced diagnostic development team supports the development of in vitro diagnostics (IVDs), companion diagnostics (CDx) and liquid biopsy advances. Zu unseren Lösungen gehören:
- Regulatory consulting and submissions, including extensive IVDR experience, to ensure you meet new and existing regulatory requirements
- Analytical support and clinical validation studies
- Access to diverse and rare patient samples
- Advanced data-driven site selection, location and study timing insights to successfully recruit within your specified window
Ihre Anforderungen. Unsere Lösungen.
Als Anbieter eines umfassenden Managements klinischer Studien der Phasen I bis IV, klinischer Pharmakologie, von Lösungen für den Patientenzugang und anderer grundlegender Dienstleistungen arbeitet Fortrea mit aufstrebenden und großen Biopharma-, Medizintechnik- und Diagnostikunternehmen zur Förderung von Innovationen im Gesundheitswesen weltweit zusammen.